நிதி பிரிவு சிறப்பம்சங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Corporate Highlights
Closed four transactions in 2020 deploying $34.8 million; additional $8.1 million deployed to existing borrowers
Income producing assets as of December 31, 2020 reached an all-time high of $206.0 million, accompanied by strong credit trends
Closed a $9.0 million transaction in March 2021, deploying $7.1 million
Received two milestone payments from Cara Therapeutics totaling $5.0 million, with SWK retaining $3.0 million and the other $2.0 million being remitted to Enteris  prior owner. 
Specialty Finance Segment Highlights:
For the fourth quarter of 2020, finance portfolio realized yield was 16.6%, compared to 20.4% for the fourth quarter of 2019
For the fourth quarter of 2020, finance portfolio effective yield was 13.8%, a 60 bps increase compared with 13.2% in the fourth quarter of 2019 ....

United States , Enteris Biopharma , Rajiv Khosla , Flowonix Medical Inc , Alimera Sciences Inc , Holdings Corporation , Sincerus Pharmaceuticals Inc , Eyepoint Pharmaceuticals Inc , Holdings Corporation Nasdaq , Cara Therapeutics , Finance Segment Highlights , Winston Black , Sincerus Pharmaceuticals , Eyepoint Pharmaceuticals , Alimera Sciences , Trio Healthcare , Flowonix Medical , Year Ended , Investors Events , Swk Holdings Corporation , ஒன்றுபட்டது மாநிலங்களில் , ராஜீவ் கோசில , ஹோல்டிங்ஸ் நிறுவனம் , ஹோல்டிங்ஸ் நிறுவனம் நாஸ்டாக் , காரா சிகிச்சை , நிதி பிரிவு சிறப்பம்சங்கள் ,